Catalyst Wire Dossier Catalyst Wire Dossier

TRAZIMERA

TRASTUZUMAB-QYYP · Pfizer Laboratories Div Pfizer Inc
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for TRAZIMERA, covering 2019-03-11 to 2026-07-08. Get the full timeline:

Most recent: EMA Authorised: Trazimera (trastuzumab) — Pfizer Europe MA EEIG

See pricing